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Basic characteristics of immunoglobulin E (IgE)
The discovery of IgE was made much later than the discovery 
of other immunoglobulin subclasses. The first clue to the 
existence of a substance responsible for hypersensitivity reactions 
was demonstrated in 1921 by Prausnitz and Kustner, and after 
only four decades (1967) it was identified as an immunoglobulin 
subclass by Ishizakas and co-workers [1]. In 1968, The WHO 
International Reference Centre for Immunoglobulins announced 
the presence of a fifth immunoglobulin isotype, IgE [2]. IgE is 
the antibody isotype that contains the ε heavy chain and it is a 
monomer with five domains in the immunoglobulin structure. 
It is normally present in plasma at a concentration of less than 
1 μg/mL and has a half-life of about 2 days in serum [3]. A new 
unit (kU/L or IU/mL) was introduced to express the level of IgE in 
peripheral blood to alleviate the inconvenience in expressing the 
very low levels of serum IgE. One kU/L is equal to 2.4 ng/mL [4].
Once produced, IgE binds to its receptor FcεR, which are of 
two main types. High-affinity receptors (FcεRI) are found on wide 
variety of cells; mast cells, basophils, antigen presenting cells, 
monocytes and platelets [5-7] whereas low-affinity receptors 
(FcεRII) are found to be expressed on B-cells [7], monocytes 
[8] and dendritic cells [9]. The role of high affinity receptors in 
the pathogenesis of allergy is well understood [2, 7] but the 
biological role of low-affinity receptors is still unclear.
The role of IgE in health and disease
IgE was discovered for its involvement in allergic reactions 
(Type I hypersensitivities). People, who have a tendency to 
develop symptoms when exposed to allergens, produce IgE 
specific to that allergen, which evokes a cascade of reactions 
[10]. In terms of evolution, it is highly unlikely that IgE evolved 
to contribute to the pathology of allergy, hence people started 
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investigating the exact role of IgE in human. It has been shown 
that the dominant role of IgE is to protect the host from parasitic 
infections, specially helminth infections [11]. Hence it is believed 
that IgE has evolved to protect the human from helminth 
infections, which once was the major threat for the survival of the 
human species [12, 13].
Role of IgE in helminth infections
IgE plays a vital role in the cross-talk between innate and 
adaptive immunity. Helminths are large parasites that can not be 
engulfed by phagocytes and could be best dealt by cytotoxic cells. 
Invasion of tissues by helminths stimulates an immune response 
which generates a cytokine milieu that shifts the TH0 cells to 
mature along the TH2 pathway. These TH2 cells secrete interleukin 
(IL) 4 which induces the B cells to switch the immunoglobulin class   
to IgE. At the same time secreted IL 5 enhances the production and 
maturation of eosinophils [14]. 
IgE molecules coat the parasite which enables the tissue mast 
cells and circulating eosinophils to bind via their IgE receptors. 
This interaction of IgE with their receptors initiates a cascade of 
reactions in these cells which results in release of histamine and 
other toxic substances to the exterior [15]. Eosionophils that are 
recruited to the site of infection release granule proteins such 
as major basic protein, eosinophil cationic protein. These toxic 
substance released from the cells in the vicinity of the invading 
parasite are capable of killing the parasite [16, 17].
IgE in allergic reactions
Understanding the role of IgE in allergic reaction has been a 
major breakthrough in the field of allergy. It has paved the way for 
the discovery of effective drugs for these diseases. The sequence 
of events in the allergic reaction consists of the production of IgE 
antibodies in response to an allergen, binding of IgE to Fc receptors 
of mast cells, cross-linking of the bound IgE by the allergen upon 
re-exposure, and release of mast cell mediators such as histamine, 
lipid mediators and cytokines. Some mast cell mediators cause 
rapid increase in vascular permeability and smooth muscle 
contraction, resulting in many of the symptoms [18, 19].
The above reaction does not take place in every individual 
when exposed to environmental allergens. People with a genetic 
predisposition, called atopics, have a personal tendency to develop 
IgE when exposed to otherwise harmless environmental allergens. 
Such individuals have allergen-specific IgE (sIgE) in their serum 
reflecting their exposure to allergens in the past [10].
Levels of total IgE (tIgE) and sIgE
The rising trend of allergic diseases in the affluent populations in 
developed countries was alarming [19]. Investigations were carried 
out to find markers of allergy in such populations. The observation 
of high levels of tIgE in allergic individuals compared to healthy 
controls lead to identifying a cut-off level of tIgE for a diagnosis 
of allergy. It was observed that the probability is very high in 
predicting allergy when the tIgE level is above 200 kU/L [20, 21]. 
Longitudinal studies have demonstrated that levels of IgE increases 
with age from birth, regardless of atopic status but the increment in 
atopic children is abrupt and continue to have high levels in adult 
hood [22, 23]. Since most somatic IgE is bound by its receptors, 
serum IgE may not necessarily reflect the systemic IgE levels. 
However, Dehlink and co-workers have been able to demonstrate 
that the level of serum IgE correlates well with cell-bound IgE [24]. 
Nevertherless, a high tIgE level alone is of limited value as a marker 
of allergy as it does not give any clue to sensitizing allergens in an 
individual. Hence, attention was paid more on sIgE as a biomarker. 
The pool of IgE in an individual is the sum of IgE produced 
against different allergens - ie: specific IgE. Presence of sIgE in 
serum indicates that the individual has been exposed to the 
allergen earlier (sensitized). Presence of sIgE against a particular 
allergen above a level of 0.35 kUA/L is deemed positive for that 
allergen [10]. A person is said to be atopic if laboratory data shows 
a positive test. It should be noted that a positive result does not 
always correlate well with the clinical feature of a person. People 
with positive test for a particular allergen may not necessarily 
get symptoms when exposed to that allergen [25, 26]. Although, 
a positive test (a level ≥ 0.35 kUA/L) for aeroallergens generally 
correlates well with the clinical expression, much controversy 
exits for food allergens [27, 28, 29]. The difficulty in defining a 
single reference value for all the food allergens has made doctors 
uncomfortable in interpreting reports. Different reference values 
for different food allergens have been suggested based on clinical 
evidence, but this makes the clinicians life extremely complicated 
when managing patients. Thus, well conducted cross-sectional and 
longitudinal studies are needed to reach a consensus in this regard.       
IgE levels in populations in tropics
Recently, there had been much interest on how the allergic 
response is modulated by helminths in people living in helminth 
endemic areas of the tropics. Serum levels of tIgE are very high 
in such people despite being non-atopic [13, 30]. Indeed, it is 
observed that the tIgE levels are several folds higher in them apallergy.org
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compared to atopic people in the developed western countries 
emphasizing the limited use of tIgE as a marker of allergy in 
tropics [13]. It is known that helminths are capable of inducing IgE 
synthesis markedly [30]. Analysis of IgE molecules in such people 
has revealed that most of these IgE are non-specific [31, 32]. It is 
postulated that polyclonal synthesis of IgE is a mechanism of the 
parasite to evade the host immune response against it [32]. The 
mechanism of immune evasion by helminths is not well elucidated 
to date. The observation of high tIgE and low sIgE levels in 
populations in tropics is interesting and needs to be explored since 
it reflects some of the facts related to the control of IgE synthesis.   
Lynch et al have reported that helminths enhance the polyclonal 
synthesis of IgE resulting in high tIgE levels, while down-regulating 
the production of sIgE [32]. This suggests that control of tIgE and 
sIgE is independent from each other. Direct evidence for this comes 
from the study done by Sunyer and colleagues, which showed that 
tIgE levels are associated with asthma even in subjects negative 
for sIgE to common aeroallergens [33]. It should be noted that the 
population for the latter study comes from an area not endemic for 
helminth infections. Reinforcing this notion, genetic studies have 
revealed different genetic loci for tIgE levels and sIgE profiles [34-
36]   
Elevated tIgE in other diseases
The presence of high levels of tIgE in allergic diseases is well 
documented. Nevertheless, there are other situations where an 
increase in the level is observed. Hyper IgE syndrome, IgE myeloma, 
some disorders of vasculitis, though rare, should be considered in 
differential diagnosis for extremely high tIgE levels [37].
Therapeutic implications
The cornerstone of an allergic reaction is the cross-linking of 
IgE molecules bound to mast cell receptors. Neutralization of IgE 
antibodies is a conceptually new approach for the treatment of 
allergic diseases. Recombinant monoclonal humanized anti-IgE has 
demonstrated promising results as a treatment for asthma in adults 
[38]. Further studies are needed to evaluate long-term safety and 
efficacy in the treatment of allergic diseases with anti-IgE treatment 
in children [39].
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